Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Spaner

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Leukocyte Biology|July 28, 2004
Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cellsDavid E Spaner
Cancer Medicine|April 18, 2025
Effect of Statins in the Watch and Wait Phase of Chronic Lymphocytic LeukemiaDavid E Spaner
Frontiers in Immunology|December 6, 2021
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood CancersDavid E Spaner
Cell Cycle (Georgetown, Tex.)|December 11, 2012
Micromanaging a large tumor suppressorYanmei Li, David E Spaner
Blood|January 6, 2011
Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemiaJelena Tomic, Brian Lichty, David E Spaner
Leukemia & Lymphoma|September 2, 2015
A link between hypercholesterolemia and chronic lymphocytic leukemiaSigny Chow, Rena Buckstein, David E Spaner
Journal of Cutaneous Medicine and Surgery|October 4, 2002
Foreign body granuloma: a new manifestation of immune restoration syndromeChristian A Murray, Joel DeKoven, David E Spaner
British Journal of Haematology|November 30, 2004
Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapyDavid E Spaner, Caitlin Hammond, Jenny Mena, et al.
Leukemia Research|January 23, 2018
Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitroFang Zhu, Lindsay McCaw, David E Spaner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2022
Enhanced IFN Sensing by Aggressive Chronic Lymphocytic Leukemia CellsTina YuXuan Luo, Yonghong Shi, Guizhi Wang, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Leukocyte Biology|July 28, 2004
Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cellsDavid E Spaner
Cancer Medicine|April 18, 2025
Effect of Statins in the Watch and Wait Phase of Chronic Lymphocytic LeukemiaDavid E Spaner
Frontiers in Immunology|December 6, 2021
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood CancersDavid E Spaner
Cell Cycle (Georgetown, Tex.)|December 11, 2012
Micromanaging a large tumor suppressorYanmei Li, David E Spaner
Blood|January 6, 2011
Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemiaJelena Tomic, Brian Lichty, David E Spaner
Leukemia & Lymphoma|September 2, 2015
A link between hypercholesterolemia and chronic lymphocytic leukemiaSigny Chow, Rena Buckstein, David E Spaner
Journal of Cutaneous Medicine and Surgery|October 4, 2002
Foreign body granuloma: a new manifestation of immune restoration syndromeChristian A Murray, Joel DeKoven, David E Spaner
British Journal of Haematology|November 30, 2004
Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapyDavid E Spaner, Caitlin Hammond, Jenny Mena, et al.
Leukemia Research|January 23, 2018
Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitroFang Zhu, Lindsay McCaw, David E Spaner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2022
Enhanced IFN Sensing by Aggressive Chronic Lymphocytic Leukemia CellsTina YuXuan Luo, Yonghong Shi, Guizhi Wang, et al.
Pageof 5